Fig. 4: Survival in patients with HER2+ nonmetastatic IDC according to AR expression (78%).

a Kaplan–Meier curve for DFS of HER2+ breast cancer patients. b Kaplan–Meier curve for OS of HER2+ breast cancer patients. c Kaplan–Meier curve for DFS of HER2+HR− breast cancer patients. d Kaplan–Meier curve for OS of HER2+HR− breast cancer patients.